Drug intelligence / Profile preview

glycerol

Development stage
Approved
Lead developer
ACO
Modality
Small Molecules
Administration
Oral, Rectal, Intravenous, Ophthalmic, Topical
01

Overview

Glycerol is a simple polyol compound that serves as a versatile pharmaceutical agent, metabolic substrate, and humectant. In clinical practice, it is utilized as an osmotic diuretic to reduce intraocular pressure in glaucoma and intracranial pressure in neurological emergencies such as glioblastoma-associated edema. Topically, glycerol is a highly effective humectant used in emollient formulations (e.g., Miniderm) to treat dry skin and atopic dermatitis by enhancing stratum corneum hydration and barrier function. Metabolically, glycerol is a key substrate for hepatic gluconeogenesis and fatty acid esterification; recent clinical research has also identified it as a precursor for de novo glutathione synthesis in the liver, a pathway that may be impaired in patients with obesity and non-alcoholic fatty liver disease (NAFLD). It is also widely used as a component in electronic cigarette liquids and as a food additive.

Brand names
MinidermMiniderm DuoMiniderm CompOsmoglynGlyrolOphthalgan
Other names
glyceringlycerine1,2,3-propanetrioltrihydroxypropane
02

Targets

AQP7 (Aquaporin-7)AQP3 (Aquaporin-3 channel protein)GCK (Glucokinase)

Beyond the preview

Go deeper on glycerol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glycerol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call